(secondQuint)A Study of the Safety of IMOVAX Polio in China.

 Study participants will receive a single dose of IMOVAX Polio cent vaccine at 2, 3, and 4 months of age, respectively.

 Each participant will make a total of 7 visits.

 Safety will be monitored at each visit and up to 30 days after each vaccination.

.

 A Study of the Safety of IMOVAX Polio in China@highlight

This study is designed to obtain post-marketing safety data on IMOVAX Polio cent vaccine in China.

 Primary Objective: To describe the safety profile after each dose of IMOVAX Polio cent administered at 2, 3, and 4 months of age in population aged over 2 months old living in the study city China.

